Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Soligenix Inc. (SNGX)

1.04   0.01 (0.97%) 01-23 16:00
Open: 1.3 Pre. Close: 1.03
High: 1.32 Low: 0.9825
Volume: 5,331,472 Market Cap: 18M

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 1.321 - 1.327 1.327 - 1.331
Low: 0.969 - 0.974 0.974 - 0.978
Close: 1.031 - 1.04 1.04 - 1.047

Technical analysis

as of: 2019-01-23 4:31:24 PM
Overall:       
Stoxline posted a NEUTRAL today, same as yesterday. Current trend continues, but could change at anytime. It is not a good time to buy or sell.
Target: Six months: 1.31     One year: 1.54
Support: Support1: 0.80    Support2: 0.67
Resistance: Resistance1: 1.12    Resistance2: 1.32
Pivot: 0.99
Moving Average: MA(5): 1.02     MA(20): 0.96
MA(100): 1.24     MA(250): 1.48
MACD: MACD(12,26): 0.01     Signal(9):
Stochastic oscillator: %K(14,3): 66.18     %D(3): 73.15
RSI: RSI(14): 56.22
52-week: High: 3.70  Low: 0.80  Change(%): -52.9
Average Vol(K): 3-Month: 15880  10-Days: 60195

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
SNGX has closed below upper band by 11.8%. Bollinger Bands are 69.6% narrower than normal. The narrow width of the bands suggests low volatility as compared to SNGX's normal range. The bands have been in this narrow range for 19 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

2019-01-23T09:12:11-05:00
UTX, SYF among premarket gainers

2019-01-23T06:31:47-05:00
Soligenix nabs new patent in Europe

2019-01-23T06:00:00-05:00
Soligenix Receives European Patent for Dusquetide and Related Innate Defense Regulator Analogs

Financial Analysis

Growth
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
atoplab.com
Tweet this page Share on Google+ Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 17.68
Shares Float (M) 7.77
% Held by Insiders
% Held by Institutions 24.20
Shares Short (K)
Shares Short P. Month (K)

Stock Financials

EPS -0.560
EPS Est. Current Year -1.480
EPS Est. Next Year -1.470
EPS Est. Next Quarter -0.340
Forward EPS -1.239
Book Value (p.s.) 1.910
PEG Ratio -1.60
Profit Margin
Operating Margin -153.60
Return on Assets (ttm) -83.2
Return on Equity (ttm) -128.2
Qtrly Rev. Growth -24.2
Gross Profit (p.s.)
Sales Per Share
EBITDA (p.s.)
Qtrly Earnings Growth
Operating Cash Flow (M) -6.89
Levered Free Cash Flow (M) -4.20

Stock Valuations

P/E -1.86
P/E Growth Ratio 0.01
P/BV 0.54
P/S 35359996.00
P/CF -2.67

Dividends & Splits

Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Forward Dividend
Last Split Date 2016-10-07
Last Split Ratio -1e+010
7 Binary Options
Your Ad Here
android_stock_chart
Stock Chart
stoxline_lite
Stoxline Lite
stoxline_pro
Stoxline Pro
Option_Calculator
Option Calculator
(c) 2006-2019 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.